Calypso Medical Technologies
10.10.2012 - Varian's 'GPS for the Body' Real-Time Tracking System Used for Prostate Patients at Leading U.K. Radiotherapy Clinic more>> 02.28.2012 - Varian Medical Systems Receives FDA 510(k) Clearance for Use of Transponder to Monitor Motion During Radiotherapy Anywhere in Body more>> 09.28.2011 - Lung Cancer Tumors Successfully Tracked in Real-Time with Calypso System During Daily Radiation Treatment more>>
Intarcia
November 15, 2012 - Intarcia Therapeutics Secures Landmark $210 Million Financing to Fund Its Global Phase 3 Program for ITCA 650 in Type 2 Diabetes more>> October 03, 2012 - Intarcia Announces Presentation of Analysis Used for Dose Selection for Global ITCA 650 Phase 3 Program for Type 2 Diabetes at EASD more>> April 02, 2012 - Intarcia Announces Expanded Appointment For Kurt Graves as Chairman, President and Chief Executive Officer more>>
NuGEN Technologies
June 25, 2012 - NuGEN Web Lecture Series - A Comparison Study of Microarray Sample Preparation Methods for Challenging Samples more>> June 25, 2012 - 2012 Genomics Grant Challenge - NuGEN Supporting NGS Studies with $10,000 Reagent Grant more>>
Optimer Pharmaceuticals
Mar 15 2013 - Optimer Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) more>> Feb 28 2013 - View Summary Optimer Reports Fourth Quarter and Fiscal Year 2012 Financial Results more>> Feb 27 2013 - Optimer Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) more>>
U-Systems